Animal study · Supplements / medicine · 17 Sept 2026
Twelve mouse “aging rate indicators” are proposed to speed tests of longevity drugs
Source: News-Medical
What the research found
Commentary (review of mouse evidence). Steven Austad, Richard Miller, Matt Kaeberlein and colleagues argue in Frontiers in Science (doi 10.3389/fsci.2026.1821393) that 12 candidate aging rate indicators — single measurements that mark a slow-aging state — could shorten mouse drug screens versus 3–4 year lifespan studies. They draw on the NIA Interventions Testing Program, which has found 14 agents or combinations that extend mouse life, eight by ≥12%, some even when started in late adulthood. Candidates are not validated in humans and are not a clinic test. Educational aging-biology notes, not an anti-aging drug protocol.
Evidence level: Animal study. Results in animals or cells often don't carry over to people.
More supplements / medicine news
- In mice, the experimental drug KCL-286 reduced DNA breaks and brain inflammation in an Alzheimer's model
- In aged rats, two weeks of the experimental drug cinaciguat cut circulating amyloid-beta about in half and brought LDL down to youthful levels
- In 104 people with a sudden retinal-artery blockage, papaverine use lined up with better functional vision in a retrospective comparison
- A Cell Metabolism letter questions whether a fasting GLP-1 level shows how many gut L-cells a person has
- In FDA reports, caffeine and stimulant supplement use was tied to cardiac arrest about 11 times more often, and 45 percent of those cardiovascular reports were ages 18 to 34